Bextra and Nuclear magnetic resonance imaging abnormal - a phase IV clinical study of FDA data
Summary:
Nuclear magnetic resonance imaging abnormal is reported as a side effect among people who take Bextra (valdecoxib), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Aredia, and have Breast cancer.
The phase IV clinical study analyzes which people have Nuclear magnetic resonance imaging abnormal when taking Bextra. It is created by eHealthMe based on reports of 20,982 people who have side effects when taking Bextra from the FDA, and is updated regularly.
What is Bextra?
Bextra has active ingredients of valdecoxib. It is often used in pain. eHealthMe is studying from 20,994 Bextra users. Check the latest studies of Bextra.
What is Nuclear magnetic resonance imaging abnormal?
Nuclear magnetic resonance imaging abnormal is found to be associated with 468 drugs and 535 conditions by eHealthMe. Check the latest studies of Nuclear magnetic resonance imaging abnormal.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
20,982 people reported to have side effects when taking Bextra.
Among them, 22 people (0.1%) have Nuclear magnetic resonance imaging abnormal.

Among these 22 people:
How long have people been on Bextra when they have Nuclear magnetic resonance imaging abnormal? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 100 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Nuclear magnetic resonance imaging abnormal when taking Bextra? *
- female: 95.45 %
- male: 4.55 %
What is the age of people who have Nuclear magnetic resonance imaging abnormal when taking Bextra? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 23.81 %
- 50-59: 4.76 %
- 60+: 71.43 %
What are other drugs people take besides Bextra? *
- Zometa: 17 people, 77.27%
- Aredia: 17 people, 77.27%
- Celebrex: 14 people, 63.64%
- Diflucan: 12 people, 54.55%
- Vitamins: 12 people, 54.55%
- Premarin: 12 people, 54.55%
- Ziac: 12 people, 54.55%
- Benicar: 12 people, 54.55%
- Prevacid: 12 people, 54.55%
- Aspirin: 11 people, 50.00%
What are other side effects people have besides Nuclear magnetic resonance imaging abnormal? *
- Osteosclerosis (an elevation in bone density): 17 people, 77.27%
- Lung Neoplasm (tumour of lung): 17 people, 77.27%
- Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 13 people, 59.09%
- Computerised Tomogram Abnormal: 13 people, 59.09%
- Gingival Infection (gum infection): 12 people, 54.55%
- Osteopenia (a condition where bone mineral density is lower than normal): 12 people, 54.55%
- Osteomyelitis (infection of bone): 12 people, 54.55%
- Metastasis (spreadable cancer to other organ from origin): 12 people, 54.55%
- Mastication Disorder (disease of chewing food): 12 people, 54.55%
- Malignant Neoplasm Progression (cancer tumour came back): 12 people, 54.55%
What are the existing conditions these people have? *
- Breast Cancer: 16 people, 72.73%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 13 people, 59.09%
- High Blood Pressure: 12 people, 54.55%
- Metastases To Bone (cancer spreads to bone): 5 people, 22.73%
- Anaemia (lack of blood): 5 people, 22.73%
- Pain In Extremity: 1 person, 4.55%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 4.55%
- Joint Pain: 1 person, 4.55%
* Approximation only. Some reports may have incomplete information.
Do you take Bextra and have Nuclear magnetic resonance imaging abnormal?
- Check whether Nuclear magnetic resonance imaging abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Bextra:
- Bextra (20,994 reports)
Nuclear magnetic resonance imaging abnormal treatments and more:
- Nuclear magnetic resonance imaging abnormal (5,432 reports)
How severe was Nuclear magnetic resonance imaging abnormal and when was it recovered:
Expand to all the drugs that have ingredients of valdecoxib:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bextra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Nuclear magnetic resonance imaging abnormal:
- Nuclear magnetic resonance imaging abnormal (468 drugs)
Browse all the conditions that are associated with Nuclear magnetic resonance imaging abnormal:
- Nuclear magnetic resonance imaging abnormal (535 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on valdecoxib (the active ingredients of Bextra) and Bextra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lansoprazole cause Epididymitis? - 3 seconds ago
- Valturna vs. Calan, side effect and effectiveness comparison - 6 seconds ago
- Drug interactions of Linzess and Amitiza - 7 seconds ago
- Could Lansoprazole cause Cartilage Atrophy? - 9 seconds ago
- Drug interactions of Oxycodone and Palladone - 13 seconds ago
- Could Temazepam cause Herpes Simplex? - 14 seconds ago
- Could Ezetimibe cause Drug Level Below Therapeutic? - 15 seconds ago
- Could Temsirolimus cause Abdominal Pain Aggravated? - 17 seconds ago
- Could Pravachol cause Ards (Acute Respiratory Distress Syndrome)? - 19 seconds ago
- Could Emtricitabine cause Hyperandrogenism? - 26 seconds ago